In epileptic patients, T2DM might develop because of mitochondrial dysfunction, adiponectin deficiency, or obesity, these three mechanisms might sequentially or concurrently induce the biological drivers of T2DM in epileptic patients (45). This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.